Cargando…

Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis

Cellular and non-cellular components of the tumor microenvironment (TME) are emerging as key regulators of primary tumor progression, organ-specific metastasis, and therapeutic response. In the era of TME-targeted- and immunotherapies, cancer-associated inflammation has gained increasing attention....

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Michael, Salamero-Boix, Anna, Niesel, Katja, Alekseeva, Tijna, Sevenich, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667643/
https://www.ncbi.nlm.nih.gov/pubmed/31396225
http://dx.doi.org/10.3389/fimmu.2019.01713
_version_ 1783440067414458368
author Schulz, Michael
Salamero-Boix, Anna
Niesel, Katja
Alekseeva, Tijna
Sevenich, Lisa
author_facet Schulz, Michael
Salamero-Boix, Anna
Niesel, Katja
Alekseeva, Tijna
Sevenich, Lisa
author_sort Schulz, Michael
collection PubMed
description Cellular and non-cellular components of the tumor microenvironment (TME) are emerging as key regulators of primary tumor progression, organ-specific metastasis, and therapeutic response. In the era of TME-targeted- and immunotherapies, cancer-associated inflammation has gained increasing attention. In this regard, the brain represents a unique and highly specialized organ. It has long been regarded as an immunological sanctuary site where the presence of the blood brain barrier (BBB) and blood cerebrospinal fluid barrier (BCB) restricts the entry of immune cells from the periphery. Consequently, tumor cells that metastasize to the brain were thought to be shielded from systemic immune surveillance and destruction. However, the detailed characterization of the immune landscape within border-associated areas of the central nervous system (CNS), such as the meninges and the choroid plexus, as well as the discovery of lymphatics and channels that connect the CNS with the periphery, have recently challenged the dogma of the immune privileged status of the brain. Moreover, the presence of brain metastases (BrM) disrupts the integrity of the BBB and BCB. Indeed, BrM induce the recruitment of different immune cells from the myeloid and lymphoid lineage to the CNS. Blood-borne immune cells together with brain-resident cell-types, such as astrocytes, microglia, and neurons, form a highly complex and dynamic TME that affects tumor cell survival and modulates the mode of immune responses that are elicited by brain metastatic tumor cells. In this review, we will summarize recent findings on heterotypic interactions within the brain metastatic TME and highlight specific functions of brain-resident and recruited cells at different rate-limiting steps of the metastatic cascade. Based on the insight from recent studies, we will discuss new opportunities and challenges for TME-targeted and immunotherapies for BrM.
format Online
Article
Text
id pubmed-6667643
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66676432019-08-08 Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis Schulz, Michael Salamero-Boix, Anna Niesel, Katja Alekseeva, Tijna Sevenich, Lisa Front Immunol Immunology Cellular and non-cellular components of the tumor microenvironment (TME) are emerging as key regulators of primary tumor progression, organ-specific metastasis, and therapeutic response. In the era of TME-targeted- and immunotherapies, cancer-associated inflammation has gained increasing attention. In this regard, the brain represents a unique and highly specialized organ. It has long been regarded as an immunological sanctuary site where the presence of the blood brain barrier (BBB) and blood cerebrospinal fluid barrier (BCB) restricts the entry of immune cells from the periphery. Consequently, tumor cells that metastasize to the brain were thought to be shielded from systemic immune surveillance and destruction. However, the detailed characterization of the immune landscape within border-associated areas of the central nervous system (CNS), such as the meninges and the choroid plexus, as well as the discovery of lymphatics and channels that connect the CNS with the periphery, have recently challenged the dogma of the immune privileged status of the brain. Moreover, the presence of brain metastases (BrM) disrupts the integrity of the BBB and BCB. Indeed, BrM induce the recruitment of different immune cells from the myeloid and lymphoid lineage to the CNS. Blood-borne immune cells together with brain-resident cell-types, such as astrocytes, microglia, and neurons, form a highly complex and dynamic TME that affects tumor cell survival and modulates the mode of immune responses that are elicited by brain metastatic tumor cells. In this review, we will summarize recent findings on heterotypic interactions within the brain metastatic TME and highlight specific functions of brain-resident and recruited cells at different rate-limiting steps of the metastatic cascade. Based on the insight from recent studies, we will discuss new opportunities and challenges for TME-targeted and immunotherapies for BrM. Frontiers Media S.A. 2019-07-24 /pmc/articles/PMC6667643/ /pubmed/31396225 http://dx.doi.org/10.3389/fimmu.2019.01713 Text en Copyright © 2019 Schulz, Salamero-Boix, Niesel, Alekseeva and Sevenich. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Schulz, Michael
Salamero-Boix, Anna
Niesel, Katja
Alekseeva, Tijna
Sevenich, Lisa
Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis
title Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis
title_full Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis
title_fullStr Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis
title_full_unstemmed Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis
title_short Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis
title_sort microenvironmental regulation of tumor progression and therapeutic response in brain metastasis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667643/
https://www.ncbi.nlm.nih.gov/pubmed/31396225
http://dx.doi.org/10.3389/fimmu.2019.01713
work_keys_str_mv AT schulzmichael microenvironmentalregulationoftumorprogressionandtherapeuticresponseinbrainmetastasis
AT salameroboixanna microenvironmentalregulationoftumorprogressionandtherapeuticresponseinbrainmetastasis
AT nieselkatja microenvironmentalregulationoftumorprogressionandtherapeuticresponseinbrainmetastasis
AT alekseevatijna microenvironmentalregulationoftumorprogressionandtherapeuticresponseinbrainmetastasis
AT sevenichlisa microenvironmentalregulationoftumorprogressionandtherapeuticresponseinbrainmetastasis